Type: Public
On the web: http://www.synthes.com
Employees: 11,426
Employee growth: 6.7%

Brittle, broken, battered bones cease to be a problem with Synthes around. The company makes devices, instruments, and implants used for the surgical treatment of bone disease or trauma. It operates through five product groups: Trauma, Spine, Cranio-Maxillofacial, Biomaterials, and (shudder)Power Tools. From the skull to the foot, the company develops, produces, and markets products for the surgical fixation, correction, and regeneration of the skeleton and related soft tissues. It works closely with the AO Foundation, a not-for-profit research organization specializing in osteosynthesis. Synthes has agreed to be acquired by Johnson & Johnson for more than $21 billion.

Key numbers for fiscal year ending December, 2010:
Sales: $3,687.0M
One year growth: 8.6%
Net income: $907.7M
Income growth: 10.2%

Officers:
Chairman: Hansjörg Wyss
President and CEO: Michel Orsinger
President, Global Operations; President, Europe, Middle East and Africa: Ciro Römer

Competitors:
DePuy
Stryker
Zimmer Holdings

© 2012 Hoover's, Inc. All rights reserved.